Abstract
A hydrazone ligand, 4-chlorobenzaldehyde hydralazine hydrazone (LH), has been synthesized. Our initial attempts to synthesize Co+2, Ni+2, Cu+2 and Zn+2 metal complexes of LH resulted in a cyclized triazole product (T). Structure of both the LH and T is characterized by single-crystal X-ray diffraction pattern analysis. Synthesis of desired metal complexes is achieved by using LH in its monohydrochloride salt form (LH.HCl), thus preventing cyclization of LH to T. Mass, IR, NMR, UV–Vis spectroscopic techniques, thermal and other physicochemical methods were used for the structural elucidation of the metal complexes. On the basis of electronic and magnetic properties of the complexes, four coordinate square-planar geometry for Ni+2 complex, while Td geometry for Cu+2 and Zn+2 complex was assigned. Around Co (II) ions, Oh geometry was assigned. In vivo antihypertensive assay of the synthesized compounds is carried out in rats with fructose-induced hypertension to measure the blood pressure and tail pulse. Copper complex and the LH have exhibited antihypertensive activity at par with the well-known antihypertensive drug hydralazine.
Similar content being viewed by others
References
V.S. Shende, U.R. Pratap, A.V. Wankhade, S.P. Zodape, J. Mol. Liq. 321, 114755 (2021)
O.F. Ajeigbe, A.O. Ademosun, G. Oboh, J. Food Biochem. 45(3), e13317 (2020)
L.W. Han, R.J. Ryu, M. Cusumano, T.R. Easterling, B.R. Phillips, L.J. Risler, D.D. Shen, M.F. Hebert, J Clin Pharmacol. 59(12), 1678 (2019)
N. Salehi, A.K. Yuan, G. Stevens, R. Koshy, W.F. Klein, Am. J. Case Rep. 19, 1216 (2018)
K. Iżykowska, Exp. Dermatol. (2020). https://doi.org/10.1111/exd.14108
D. L. Barbeau, US Patent 6825196 filed on 5, March (2002).
D. L. Barbeau, US Patent 6821974 filed on 27, November (2002).
E. pahlavani, H. Kargar, N. Sepehri Rad, J. Res. Med. Sci. 17(7), e1010 (2015)
R. Kia, H. Kargar, J. Coord. Chem. 68(8), 1441 (2015)
H. Kargar, M. Fallah-Mehrjardi, R. Behjatmanes-Ardakani, K.S. Munawar, M. Ashfaq, M.N. Tahir, J. Mol. Str. 1250(2), 131691 (2022)
H. Kargar, M. Fallah-Mehrjardi, R. Behjatmanes-Ardakani, K.S. Munawar, M. Ashfaq, M.N. Tahir, Inorg. Chim. Acta 526, 10535 (2021)
H. Kargar, M. Nateghi-Jahromi, M. Fallah-Mehrjardi, R. Behjatmanes-Ardakani, K.S. Munawar, S. Ali, M. Ashfaq, M.N. Tahir, J. Mol. Str. 1249, 131645 (2022)
C.J. Rha, H. Lee, C. Kim, Inorganica Chim. Acta 511, 119788 (2020)
M. Milenković, I.N. Shcherbakov, L.D. Popov, S.I. Levchenkov, S.A. Borodkin, G.G. Alexandrov, Polyhedron 121, 278 (2017)
S. Zaib, I. Khan, Bioorg. Chem. 105, 104425 (2020)
R.P. Bakale, A.H. Pathan, G.N. Naik, S.S. Machakanur, C.V. Mangannavar, I.S. Muchchandi, K.B. Gudasi, Appl. Organomet. Chem. 28, 720 (2014)
R.P. Bakale, G.N. Naik, S.S. Machakanur, C.V. Mangannavar, I.S. Muchchandi, K.B. Gudasi, J. Mol. Struct. 1154, 92 (2018)
A.H. Romero, J. Rodríguez, Y.G. Marchan, J. Leañez, X.S. Martín, S.E. López, Bioorg. Chem. 72, 51 (2017)
D.D. Perrin, W.L.F. Armarego, Purification of Laboratory Chemicals (Pergamon Press, New York, 1988)
G. M. Sheldrick, SHELXTL. Version 5.0, Bruker AXS Inc, Madison, Wisconsin, USA, (2001).
G. Dutkiewicz, C. S. Chidan Kumar, H. S. Yathirajan, A. N. Mayekar, M. Kubicki, Acta Cryst. E65, 2694 (2009).
V.A. Kogan, S.I. Levchenkov, L.D. Popov, I.A. Shcherbakov, Russ. J. Gen. Chem. 79, 2767 (2009)
A.A. Shoukry, M.M. Shoukry, Spectrochim. Acta, Part A 70, 686 (2008)
R.P. Bakale, G.N. Naik, C.V. Mangannavar, I.S. Muchchandi, I.N. Shcherbakov, C. Frampton, K.B. Gudasi, Eur. J. Med. Chem. 73, 38 (2014)
A.A. Sharfalddin, A.H. Emwas, M. Jaremko, M.A. Hussien, Appl. Organomet. Chem. 35, e6041 (2021)
A.M. Alosaimi, I.E. Mannoubi, S.A. Zabin, Orient. J. Chem. 36(3), 373 (2020)
M.A. El-ghamry, H.F. El-Shafiy, Appl. Organomet. Chem. 35(6), e6206 (2021)
S. Mandal, S. Chatterjee, R. Modak, Y. Sikdar, B. Naskar, S. Goswami, J. Coord. Chem. 67, 699 (2014)
Acknowledgements
Financial support was provided by DST (Project No.-INT/RFBR/P-13). Author Dr. Raghavendra P. Bakale is thankful to UGC-RFSMS for the scholarship. Thanks to USIC, Karnatak University, Dharwad, for the spectral facilities.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Below is the link to the electronic supplementary material.
13738_2022_2658_MOESM1_ESM.docx
1H, 13C, 135DEPT, H–H COSY and C–H COSY NMR of LH; 1H, 13C NMR of Zn+2 complex; 1H NMR spectra of nickel complex; ESI–MS of ligand, Co+2, Ni+2 and Zn+2 complex; thermograms of Co+2, Ni+2, Cu+2 and Zn+2 complex are provided as supplementary material. Supplementary file1 (DOCX 1999 kb)
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bakale, R.P., Naik, G.N., Machakanur, S.S. et al. Synthesis, characterization, spectroscopic properties and antihypertensive activity of 4-chlorobenzaldehyde hydralazine hydrazone and its metal complexes. J IRAN CHEM SOC 20, 147–154 (2023). https://doi.org/10.1007/s13738-022-02658-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-022-02658-w